Study Evaluating Local Susceptibility Patterns Associated With Tigecycline in Comparison to Other Antibiotics
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01311349|
Recruitment Status : Completed
First Posted : March 9, 2011
Last Update Posted : March 9, 2011
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||1575 participants|
|Official Title:||Evaluation of the Antimicrobial Activity In Vitro of Tigecycline in Comparison to Other Broad Spectrum Antibiotics in Isolates Collected From Patients|
|Study Start Date :||December 2005|
|Actual Study Completion Date :||September 2006|
A listing of all isolates meeting the inclusion criteria will be maintained.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01311349
|Study Director:||Medical Monitor||Wyeth is now a wholly owned subsidiary of Pfizer|